| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |